Chào mừng trở lại
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Tham gia Cointime
Đã có tài khoản?
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Đăng nhập với email
Đăng nhập với
Email của bạn
Đăng ký
Bấm vào liên kết chúng tôi gửi tới để đăng nhập
Nhấp vào liên kết chúng tôi đã gửi tới để đăng ký.
Cytonics
company
About
Cytonics is a biotechnology company developing diagnostic assays focusing on musculoskeletal-related pain.
- 51 - 100
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $1.60M
- Industries
- Biotechnology,Fitness,Health Diagnostics
- Founded date
- Jan 1, 2006
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Cytonics Corporation, a biotechnology company, develops diagnostic assays focusing on musculoskeletal related pain. It offers Fibronectin Aggrecan Complex Test (FACT) for molecular discography and FACT Plus multi analyte assay for diagnosing the source of pain in the spine and joints. Additionally, the company provides proteomics research and development services. Cytonics Corporation was founded in 2006 and is based in Jupiter, Florida.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$1.60M
Cytonics has raised a total of
$1.60M
in funding over 2 rounds. Their latest funding was raised on
Nov 14, 2012 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 14, 2012 | Grant | $1.60M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Cytonics is funded by 1 investors.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
